|Year : 2016 | Volume
| Issue : 46 | Page : 195-200
The anticholinesterase properties of plants from the northeast of brazil selected by an ethnopharmacological study for disorders relating to the nervous system
Valerium Thijan Nobre de Almeida e Castro1, Tadeu Jose da Silva Peixoto Sobrinho2, Allan Jonathan Chernichiarro Corrêa1, Thiago Antonio de Sousa Araújo3, Terezinha Gonçalves Da Silva4, Elba Lucia Cavalcanti de Amorim1
1 Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, Recife, Brazil
2 University Center Valley Ipojuca, Caruaru, Brazil
3 Health Sciences Center, Federal University of Tocantins, Palmas, Brazil
4 Department of Antibiotics, Health Sciences Center, Federal University of Pernambuco, Recife, Brazil
|Date of Submission||12-Aug-2015|
|Date of Decision||17-Sep-2015|
|Date of Web Publication||11-May-2016|
Valerium Thijan Nobre de Almeida e Castro
Department of Pharmacy, Federal University of Pernambuco, Health Sciences Center, Prof. Arthur de Sa Avenue, Pernambuco, 50670-901
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Various factors may trigger Alzheimer's disease and the cholinergic hypothesis, which is one of the most widely accepted, argues damage to the brain nuclei, may reduce the production of the choline acetyltransferase enzyme, and cause a decline in the synthesis of acetylcholine (ACh). Studies have thus focused on discovering molecules that are capable of inhibiting the action of cholinesterase enzymes that degrade ACh, thereby preventing the evolution of the disease. Objective: The aim of the present study is to assess the anticholinesterase properties of extracts of medicinal plants in a semi-arid region of Northeast of Brazil. Materials and Methods: The species were selected by way of an ethnobotanical study and were collected if there were some indications that they are related to the nervous system. The plant samples were extracted using hexane, ethyl acetate, and methanol. Anticholinesterase activity in vitro was assessed by way of bioautography in thin layer chromatography and microassays in 96-well plates. Results: Twenty-three species of plant were collected, and 75 extracts were analyzed. The bioautography revealed that 26.7% of the samples showed inhibitory activity against the acetylcholinesterase (AChE) enzyme. After the test for false positives, 8% of the samples were found to inhibit AChE. Thirty samples were analyzed by microassay (500 μg/mL), on which 86.7% showed moderate to powerful anticholinesterase activity. Conclusion: Of the extracts tested, Citrus limonum, Ricinus communis, and Senna occidentalis stand out as was the most promising in terms of anticholinesterase activity and may serve as a guide for the discovery and development of new substances for the treatment of AD.
- The bioautography revealed that 26.7% of the samples showed inhibitory activity against the acetylcholinesterase enzyme
- Samples were analyzed by microassay (500 μg/mL), upon which 86.7% showed moderate to powerful anticholinesterase activity
- Citrus limonum, Ricinus communis, and Senna occidentalis stand out as being the most promising in terms of anticholinesterase activity
- C. limonum, R. communis, and S. occidentalis may serve as a guide for the discovery and development of new substances for the treatment of Alzheimer's disease.
Abbreviations used: AChE: Acetilcolinesterase
Valerium Thijan Nobre de Almeida e Castro
Keywords: Acetylcholinesterase, Alzheimer′s disease, Caatinga, dementia, semi-arid
|How to cite this article:|
de Almeida e Castro VT, Sobrinho TJ, Corrêa AJ, de Sousa Araújo TA, Da Silva TG, de Amorim EL. The anticholinesterase properties of plants from the northeast of brazil selected by an ethnopharmacological study for disorders relating to the nervous system. Phcog Mag 2016;12, Suppl S2:195-200
|How to cite this URL:|
de Almeida e Castro VT, Sobrinho TJ, Corrêa AJ, de Sousa Araújo TA, Da Silva TG, de Amorim EL. The anticholinesterase properties of plants from the northeast of brazil selected by an ethnopharmacological study for disorders relating to the nervous system. Phcog Mag [serial online] 2016 [cited 2022 Nov 26];12, Suppl S2:195-200. Available from: http://www.phcog.com/text.asp?2016/12/46/195/182166
| Introduction|| |
Alzheimer's disease (AD) can be classified as sporadic or familial. The first type affects 90–95% of individuals, and most of these are aged over 60 years. The second type manifests itself in people under 60 years of age and is present in other family members, characterizing it as a disorder of genetic origin. This makes the study of this disease even more important owing to the increased life expectancy of human beings. In Brazil, in the past decade, the population aged 60 years or above has grown 2.5 times more (36%) than the younger population (14%) and the United Nations estimates that the elderly population, which currently exceeds 840 million, will triple by 2050.
The principal anatomical and physiological characteristics of AD are degradation of the cholinergic neurons and reduction in acetylcholine (ACh), which together result in dementia, the main symptom of the disease. Histopathological studies show senile plaques formed by fragments of insoluble β-amyloid peptide and intracellular neurofibrillary tangles, which may be formed by disruption of the microtubule cytoskeleton, due to hyperphosphorylation of TAU protein, accompanied by massive loss of neurons.
The production of ACh depends on the functioning of the base nuclei, especially Meynert's nucleus since this produces the enzyme that catalyzes the synthesis of ACh known as choline acetyltransferase (CAT). When these nuclei atrophy, there may be diminished production of CAT and hence, reduced production of the ACh neurotransmitter.
The recycling of ACh in the synaptic cleft is carried out by the acetylcholinesterase enzyme (AChE) and butyrylcholinesterase enzyme, which are found in various organs and are capable of degrading ACh into choline and acetyl-CoA. The main drugs used to treat AD are therefore cholinesterase inhibitors (ChIs) which allow ACh to remain longer in the synaptic cleft.
Starting out from the cholinergic hypothesis, various studies have looked for active substances based on natural sources. The alkaloids physostigmine, extracted from Physostigma venenosum, and galantamine, extracted from the Galanthus and Narcissus genera, have powerful anticholinesterase properties although their side effects include hepatotoxicity, gastrointestinal problems, and others relating to bioavailability.
In view of this, various studies have been conducted to find new substances based on natural products, especially plants that are capable of inhibiting the action of AChE, in an attempt to mitigate the effects of AD, and have fewer side effects than the currently available drugs.,,
Some studies are based species selection on traditional knowledge, for example a triage with extracts from 18 traditionally used species related to the inhibition of AChE that showed promising candidates as Jatropha gossypifolia and Senna alata, which have a level of activity similar to the standard galantamine. Another study has evaluated the hydroalcoholic extract and fractions of Bouvardia ternifolia as ChIs and obtained moderately good results for the raw extract, and ethyl acetate and methanol-soluble fractions.
The classes of compounds that have been most frequently isolated and identified in studies of anticholinesterase activity are alkaloids, followed by monoterpenes, coumarins, triterpenes, flavonoids, and benzenoids.
The present study thus aims to evaluate the anticholinesterase activity of 75 plant extracts traditionally used to treat disorders of the nervous system in an attempt to find substances that may lead to new treatment options for AD.
| Materials and Methods|| |
Selection of species
The plant samples were collected in a semi-arid part of the municipality of Altinho, in the Brazilian State of Pernambuco (08° 35'13.5” S and 36° 05'34.6” W). The selection of species was based on popular use in the treatment of disorders of the nervous system according to a data bank built up by the Laboratory of Applied Ethnobotany of the Federal Rural University of Pernambuco – PEUFR.
After this survey, species were excluded if they were bought in local markets and/or fairs or not easily available in the environment. Medicinal plants were selected for inclusion in the study if they were recommended by at least three informants for the treatment of some symptom or pathology related to the nervous system, such as headache, dizziness, insomnia, migraine, and forgetfulness, yielding 23 species. Of these, the bark and leaves were collected from Erythrina velutina and Anadenanthera colubrina, providing a total of 25 plant samples [Table 1].
|Table 1: Result of qualitative analysis of 75 extracts tested using the silica plate test for anticholinesterase activity of medicinal plants collected in a semi-arid part of the municipality of Altinho/PE |
Click here to view
Vouchers of the selected species were identified at the Applied Ethnobotany Laboratory of Federal Rural University of Pernambuco (PEUFR) with the aid of the keys for botanical identification and specialized bibliography. The material collected was deposited in the Professor Vasconcelos Herbarium collection, Federal Rural University of Pernambuco (PEUFR), and copies were included in the Professor Geraldo Mariz Herbarium, collection Federal University of Pernambuco, Pernambuco, and the Agronomic Institute of Pernambuco.,
Obtaining the extracts
The samples collected were stabilized in a dryer at 40 ± 2°C for 3 days and then ground in a Willey type knife mill to obtain a 20 Mesh particle size. The powders (50 g) were extracted by maceration with 250 mL of hexane for 48 h and once filtered, the solvent was replenished 3 times. The plant residue was then extracted with ethyl acetate and methanol, respectively, as described previously. Hexane, ethyl acetate, and methanol extracts were produced for all 25 plant samples, giving a total of 75 extracts. The fluid extracts were pooled together and concentrated under reduced pressure at 40 ± 2°C to obtain the dry extracts.
The acetylcholinesterase was obtained from Electrophorus electricus (AChE, Type VI-S), bovine serum albumin (BSA), physostigmine, acetylthiocholine iodide (ATCi), and Ellman's reagent 5,5'-dithiobis- (2-nitrobenzoic acid) from Sigma (St. Louis, MO, USA). The ethyl acetate, hexane, methanol, and other reagents were acquired from Vetec Química Fina, Brazil.
Acetylcholinesterase inhibition assay
Bioautography of Acetylcholinesterase inhibition
This assay was divided into two stages using a modified version of the method described by Rhee et al. A pretest was first carried out with the raw extracts (10 mg/mL) and positive standard physostigmine (0.1 mM) which were analyzed using thin layer chromatography (TLC) F254 silica gel plates from Merck (Darmstadt, Germany). Aliquots of 2.5 µL of the samples and standard were applied to the plate and sprayed with a solution of Ellman's reagent (1 mM) and ATCi (1 mM) diluted in a Tris/HCl buffer (50 mM, pH 8). After drying, the plates were sprayed with the AChE solution (3 U/mL) diluted in a Tris/HCl buffer (50 mM, pH 8) containing 0.1% BSA. After 5 min, white inhibition haloes were visualized on the yellow coloring of the plate.
A “false positive” test was then carried out to confirm inhibition of the enzyme. Another plate of TLC was prepared in a similar manner although first sprayed with Ellman's reagent and, after drying, the ATCi and AChE solution (preheated to 37°C for 10 min). In a few minutes, the yellow coloring appeared on the plate, and it was checked for the presence of white haloes. The extracts that did not form haloes on the “false positive” test even though these were present in the pretest were considered positive. To confirm the results obtained in the qualitative tests, the species that exhibited activity in the pretest, regardless of the polarity of the extract, was tested quantitatively to compare the two methodologies and to check the significance and authenticity of the false-positive test.
Acetylcholinesterase inhibition micro-assay
The AChEI activity microplate assay was based on Ellman's method (1961) as modified by Rhee et al. Readings were taken using a Thermo-Plate automatic 96-well microplate reader (Mod. TP-Reader). The raw extracts (500–2000 μg/mL) were diluted in a Tris/HCl buffer (50 mM, pH 8) containing 0.1 M of NaCl and 0.02 M of MgCl2, and the positive standard physostigmine (0.10–1.35 mg/mL) was diluted with methanol. The negative control was methanol in a Tris/HCl buffer (50 mM, pH 8) in place of the sample/standard.
Aliquots of 25 μL of ATCi (15 mM) diluted in a Tris/HCl buffer (50 mM, pH 8), 125 μL of Ellman's reagent (3 mM) diluted in a Tris/HCl buffer (50 mM, pH 8), 50 μL of Tris/HCl buffer (50 mM, pH 8) containing 0.1% BSA, and 25 μL of the sample were placed in the wells. The absorbance of the wells was determined over a period of 5 min at 412 nm. Finally, 25 μL of AChE enzyme (0.22 U/mL) diluted in Tris/HCl buffer (50 mM, pH 8) containing 0.1% BSA was added. The absorbance was again measured over a period of 5 min. All analyses were carried out in triplicate.
The percentage of inhibition was calculated by comparing the absorbance of the samples compared to the blank (Tris/HCl buffer at 50 mM and pH 8) according to the following equation:
All the data were expressed in terms of mean ± mean standard error. The comparison of inhibition data was carried out using ANOVA analysis of variance, followed by the Tukey test for comparing the % inhibition of anticholinesterase between species and concentrations of extract (P < 0.05). These analyses were carried out using Bio Estat 5.0 (Mamiraua Institute) (Ayres et al. 2007). The graphs were plotted using GraphPad Prism5 (GraphPad Software, Inc.).
A scale, adapted for microplate assays, was used to classify anticholinesterase activity, according to which acetylcholinesterase inhibition (AChEI) ≤30% are classified as weak inhibitors, 30–50% moderate inhibitors, and ≥50% strong inhibitors and candidates for future fractioning.
| Results and Discussion|| |
The false-positive and positive results from the pretests are presented in [Table 1]. Of the 75 samples examined, 20 extracts (26.7%) produced a white halo on the yellow background in the pretest for AChE enzyme inhibition activity. When the false-positive test was carried out, six extracts from four species exhibited activity, representing 8% of the total number of samples analyzed.
A. colubrina (angico), A. speciosa (shell plant), Mimosa tenuiflora (jurema preta), and Ricinus communis (castor oil plant) were the species that tested positive. In the case of Mimosa tenuiflora, the test was positive for the hexane and ethyl acetate extracts, whereas the methanol extract produced a false positive.
The two silica gel plate tests were capable of identifying spots indicating false positive results, which may be attributed to compounds such as aldehydes and amines present in the extracts that inhibit the reaction between Ellman's reagent and the substrate originating from hydrolysis of acetylthiocholine by AChE.
The ethyl acetate extracts of Prosopis juliflora, Hymenaea courbaril, and Citrus limonum, which did not produce spots in the pretest, did produce white spots in the false positive test.
Acetylcholinesterase enzyme inhibition micro-assay
Thirty-nine samples from 13 species that produced inhibition spots in silica gel plates in the pretest were selected for the microplate assay, with the exception of the extract of P. juliflora and the hexane extract of H. courbaril, for reason of the low yield and the impossibility of collecting more samples for the preparation of further extracts without impairing the ability to undertake faithful comparisons, owing to the different time of the year and the effect of this on such comparisons. It is known that such factors are responsible for qualitative and quantitative modifications of the secondary metabolites. It should also be noted that only the bark of A. colubrina and E. velutina tested positive in silica plates and were submitted to the quantitative test,;the leaves of these species were not used for the microplate assay.
Of the 35 samples tested quantitatively, the ethyl acetate extracts of A. speciosa, Amburana cearenses, A. colubrina, Cedrela odorata, and Commiphora leptophloeos produced results that were negative and/or close to zero and considered nondetectable (ND), leaving 30 samples for statistical analysis.
The AChEI percentages (t = 5 min) of the extracts at three concentrations (500, 1000, and 2000 μg/mL), on the last reading of the microplate, were analyzed statistically to ascertain whether there was a significant difference between the concentrations used [Table 2], since the lower the quantity of extract used in relation to activity, the more promising the extract for drug development. A lower concentration of physostigmine (0.10 mg/mL) showed 92.87% inhibition.
|Table 2: Statistical analysis of acetylcholinesterase enzyme inhibitors percentages (t=5 min) for hexane, ethyl acetate and methanol extracts at 500, 1000, and 2000 ìg/mL |
Click here to view
Among hexane extracts, R. graveolens, S. occidentalis and E. velutina showed higher percentage of anticholinesterase inhibition on the basis of the lowest concentration tested [Table 2].
In general terms, the hexane fraction of R. graveolens at a concentration of 1000 μg/mL can be considered more promising since it yielded a higher inhibition percentage (74.14%) compared to the other species, not differing statistically from the concentration of 2000 μg/mL (74.37%). This is an interesting finding since it suggests that it would not be necessary to use higher concentrations to obtain a satisfactory result. However, as the literature and studies of R. graveolens have shown extracts of this species to produce toxic effects, more attention needs to be paid to this aspect.
In a study of the anticholinesterase activity of methanolic and aqueous extracts of R. graveolens, 39% and 22% inhibition of AchE, respectively, were found for a concentration of 0.1 mg/mL. Another study has used the same Ellman's method to investigate methanolic and hexane extracts of R. graveolens, finding 59% and 95% inhibition, respectively, at a concentration of 0.4 mg/mL.
In the case of ethyl acetate extracts, S. occidentalis, R. communis, C. limonum, and Mimosa tenuiflora exhibited the highest percentage of anticholinesterase activity, at the lowest concentration tested [Table 2]. In the case of S. Ocidentalis and R. communis, there was no significant difference between the three concentrations tested. With M. tenuiflora and C. limonum, an increased concentration contributed positively to an increase in inhibitory action although the concentration of 2000 μg/ml was the most efficient for these extracts of these species.
This same group of plants also presented the best inhibition percentage results for the most polar fraction. In particular, an increase in concentration of the extract of S. occidentalis decreased inhibitory activity. In the case of the methanol extracts of R. comunins and C. limonum, the concentration of 500 μg/mL did not differ statistically from higher concentrations. Of these species, M. tenuiflora showed important activity in terms of inhibition and as with the ethyl acetate extracts, an increase in concentration positively influenced AchE inhibition, varying from 65.49% to 80.77%.
It can be seen that 66.7% of samples showed no significant difference as to the concentration used for the extract. However, those which did show some difference included species such as C. limonum, M. tenuiflora, and R. communis, which produced the best results.
It should be noted that ethnobotanical studies and plant diversity are important for AChEI research, as these provide a wide variety of metabolites conducive to phytochemical studies. Although most anticholinesterase studies concentrate on the search for alkaloids, in view of the discovery of physostigmine in P. venenosum and more than 35 alkaloids reported to be active in inhibiting acetylcholinesterase, an increasing number of other classes of the compound have been related to such activity, including terpenoids, glycosides, and coumarins.
Flavonoids, essential oils, coumarins, and pectins  are abundant in species of the genus Citrus. Leaves of Citrus aurantifolia (Christm.). Swingle were tested for in vivo AChE inhibition  and presented positive results. Good results were also obtained in vitro and in vivo for a mixture of coumarins from the ethyl acetate extract of C. limonum, suggesting a possible application for this mixture in the treatment of neurodegenerative disorders such as AD.
Pharmacological tests have been carried out in vivo with ricinine alkaloid isolated from R. communis to analyze its stimulant effect on the central nervous system. This study found a number of side effects, although at lower doses, there was an improvement in cognition, and the authors thus propose the hypothesis that substances similar to ricinine might emerge as a new class of drugs for treating diseases such as AD.
A survey covering 175 references to natural products with anticholinesterase activity, citing 309 species and 260 substances isolated from plants has shown different results for the genus Mimosa. The study of Mimosa acustipula found 39% AchE inhibition in a microplate test using a concentration of 1.8 mg/mL and another study involving Mimosa pudica at a concentration of 0.1 mg/mL found it to be inactive. Yet, another study cites various compounds that have been isolated from Mimosa hostilis and tested a group of isolated flavonoids for anticholinesterase activity, some of which exhibited positive activity ranging from 9.34% to 27.63% although this is well below the positive standard physostigmine which inhibited 94.83% of the AchE enzyme.
Qualitative × quantitative analysis
One interesting detail of the results is that the qualitative analysis filter for the choice of extracts for the quantitative test showed that one of the four extracts that presented a positive result (the ethyl acetate extract of Anadenanthera colubrine) exhibited no detectable inhibition activity.
Another quantitative result that appears controversial when using the qualitative test as a criterion for selection of extracts for positive tests is that for Mimosa tenuiflora, which, in principle, corroborated the results of the (qualitative) silica gel plate test, showing moderate to strong inhibition, ranging from 44.1% to 80.7% for the hexane and methanol extracts, respectively. The latter, however, produced a false-positive result in the qualitative test, showing that the qualitative analysis may also have presented a false-negative and suggesting that it might be useful to carry out a microplate test even for false positives.
In a study similar to the present one, CCD analysis of extracts of medicinal plants found that some samples produced stains in both positive and false-positive tests and others only in the false positive test, corroborating our results. This same study suggested that active compounds may bond with the silica to produce lower activity.
On the other hand, another study has reported that given that extracts with an enzyme percentage inhibition percentage of less than 30% were false-positive, the CCD tests were more than 80% reliable in comparing them with the microplate tests and thus conclude that this is a reliable methodology to guide future analyses.
Enzyme availability behavior profile
The AChE enzyme inhibition activity of extracts during 5 min of reaction is presented in [Figure 1]. The profile is similar for practically all the species, with a notable reduction in AChEI, represented by the increase in the percentage of AChE available on the curve over time, suggesting a reversible bonding of anticholinesterase substances with the enzyme. The ethyl acetate extract of R. graveolens behaved differently, with only 50% of the acetylcholinesterase available for reaction present after only the 1st min of reaction time.
|Figure 1: Enzymatic behavior of acetylcholinesterase enzyme over 5 min of reaction time of hexane (a), ethyl acetate (b), and methanol extracts (c) at a concentration of 500 μg/mL|
Click here to view
It should be noted that the behavior of standard serine (100 µg/mL) differs from that of the extracts, in so far as the powerful anticholinesterase activity is represented on the curve only by the small quantity of AChE available (<10%) throughout the 5-min reaction time.
| Conclusion|| |
The results obtained suggest the conclusion that ethnobotanical studies have much to contribute to research into bioactive substances since 86.7% of the samples analyzed in the microplate assay exhibited moderate to strong AChEI activity at the lowest concentration of 500 µg/mL.
C. limonum, R. communis, and S. occidentalis possess anticholinesterase potential, and a biologically guided study may favor the isolation and identification of active molecules, contributing to the arsenal of treatments available for AD.
Financial support for the development of the project by the Foundation and Support for Science of the Pernambuco State – FACEPE and the staff of the Applied Ethnobotany Laboratory – LEA, for their support in species identification and preparation of the ethnopharmacological database search.
Financial support and sponsorship
Financial support for the development of the project by the Foundation and Support for Science of the Pernambuco State - FACEPE.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Harman D. Alzheimer's disease: A hypothesis on pathogenesis. J Am Aging Assoc 2000;23:147-61.
United Nations. Department of economic and social affairs, population division. World Population Ageing. New York: United Nations; 2013. p. 95.
Viegas FP, Simões MC, Rocha MD, Castelli MR, Moreira MS, Viegas Junior C. Alzheimer's disease: Characterization, Evolution and Implications of neuroinflammatory process. Rev Virtual Quim 2011;3:286-306.
Minett TS, Bertolucci PH. Cholinergic treatment in Alzheimer's disease. Rev Neurociências 2000;8:11-4.
Forlenza OV. Pharmacological treatment of Alzheimer's disease. Rev. Psiq. Clín 2005;32:137-48.
Murebwayire S, Ingkaninan K, Changwijit K, Frédérich M, Duez P. Triclisia sacleuxii
(Pierre) Diels (Menispermaceae
), a potential source of acetylcholinesterase inhibitors. J Pharm Pharmacol 2009;61:103-7.
Cardoso-Lopes EM, Carreira RC, Agripino DG, Torres LM, Cordeiro I, Bolzani VS, et al
. Screening for antifungal, DNA-damaging and anti-cholinesterasic activities of Brazilian plants from the Atlantic Rainforest – Ilha do Cardoso State Park. Braz J Pharmacogn 2008;18 Suppl:655-60.
Herrera-Ruiz M, García-Morales G, Zamilpa A, González-Cortazar M, Tortoriello J, Ventura-Zapata E, et al
. Inhibition acetyl cholinesterase activity by hidroalcoholic extract and their fractions of Bouvardia ternifolia
(Cav.) Shcltdl (Rubiaceae
). Bol. latinoam. Caribe plantas med. aromát 2012;11:526-41.
Satheeshkumar N, Mukherjee PK, Bhadra S, Saha BP. Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum
L and its constituents. Phytomedicine 2010;17:292-5.
Feitosa CM, Freitas RM, Luz NN, Bezerra MZ, Trevisan MT. Acetylcholinesterase inhibition by somes promising Brazilian medicinal plants. Braz J Biol 2011;71:783-9.
Barbosa Filho JM, Medeiros KC, Diniz MF, Batista LM, Athayde Filho PF, Silva MS, et al
. Natural products inhibitors of the enzyme acetyl cholinesterase. Braz J Pharmacogn 2006;16:258-85.
Nascimento VT, Moura NP, Silva Vasconcelos MA, Maciel MI, Albuquerque UP. Chemical characterization of native wild plants of dry seasonal forests of the semi-arid region of Northeastern Brazil. Food Res Int 2011;44:2112-9.
Silva Fdos S, Albuquerque UP, Costa Júnior LM, Lima Ada S, do Nascimento AL, Monteiro JM. An ethnopharmacological assessment of the use of plants against parasitic diseases in humans and animals. J Ethnopharmacol 2014;155:1332-41.
Rhee IK, van de Meent M, Ingkaninan K, Verpoorte R. Screening for acetylcholinesterase inhibitors from Amaryllidaceae
using silica gel thin-layer chromatography in combination with bioactivity staining. J Chromatogr A 2001;915:217-23.
Rhee IK, van Rijn RM, Verpoorte R. Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography. Phytochem Anal 2003;14:127-31.
Ellman GL, Courtney KD, Andres V Jr., Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
Adewusi EA, Steenkamp V.In vitro
screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Southern Africa. Asian Pac J Trop Med 2011;4:829-35.
Gobbo Neto L, Lopes NP. Medicinal plants: Factors influencing the content of secondary metabolites. Quim Nova 2007;30:374 81.
Serrano Gallardo LB, Soto Domínguez A, Ruiz Flores P, Nava Hernádez MP, Morán Martínez J, Garcia Garza R, et al.
Toxic Effect of Aqueous Extract Ruta graveolens Northern Mexico on Wistar rat liver. Int J Morphol 2013;31:1041-8.
Adsersen A, Gauguin B, Gudiksen L, Jäger AK. Screening of plants used in Danish folk medicine to treat memory dysfunction for acetylcholinesterase inhibitory activity. J Ethnopharmacol 2006;104:418-22.
Wszelaki N, Kuciun A, Kiss AK. Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity. Acta Pharm 2010;60:119-28.
Viegas Junior C, Bolzani VS, Furlan M, Fraga CA, Barreiro EJ. natural products as candidates for useful drugs in the treatment of Alzheimer's disease. Quim Nova 2004;27:655-60.
Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine 2007;14:289-300.
Kuster RM, Rocha LM. Coumarins, chromone and xanthones. In: Simões CM, Shenkel EP, Gosmann G, Mello JC, Mentz LA, Petrovick. PR, editors. Pharmacognosy: the plant to medicament. 5th
ed. Porto Alegre: Editora da UFRGS, Florianópolis: 2003. p. 247-62.
Gupta A, Gupta R. A survey of plant for presence of cholinesterase activity. Phytochemistry 1997;46:827-31.
Carvalho RB, Almeida AA, Freitas RM, Lima LS, David JP, David JM, et al.
Chemical composition and anticholinesterase activity of an active fraction of a leaf extract of Citrus limon (L.) Burm. Quim Nova 2013;36:1375-9.
Ferraz AC, Angelucci ME, Da Costa ML, Batista IR, De Oliveira BH, Da Cunha C. Pharmacological evaluation of ricinine, a central nervous system stimulant isolated from Ricinus communis
. Pharmacol Biochem Behav 1999;63:367-75.
Cruz MP. Isolation and Identification of Bioactive Compounds in Mimosa hostilis Benth. D. Thesis. Bahia, Brazil: Chemistry Institute, Federal University of Bahia; 2013.
Trevisan MT, Macedo FV. Selection of plants with anti cholinesterase activity in the treatment of Alzheimer's disease Quím Nova 2003;26:301-4.
| Authors|| |
Valerium Thijan Nobre de Almeida e Castro He graduated in pharmaceutical sciences from the Federal University of Pernambuco (UFPE) and Master of Science in the same institution, which is currently a member of the Laboratory of natural products - LAPRONAT and develops Ph.D. research in Pharmaceutical Sciences. It has experience in research of natural products and bioactives. He teaches at course of Pharmacy at the University Mauricio de Nassau (UNINASSAU).
[Table 1], [Table 2]
|This article has been cited by|
||Biotechnological potential of medicinal plant Erythrina velutina Willd: A systematic review
| ||Juliana Lopes Souza, Valdinete Vieira Nunes, Crislaine Costa Calazans, Renata Silva-Mann |
| ||Biocatalysis and Agricultural Biotechnology. 2022; : 102488 |
|[Pubmed] | [DOI]|
||An insight into Cochlospermum planchonii extracts obtained by traditional and green extraction methods: Relation between chemical compositions and biological properties by multivariate analysis
| ||Stefano Dall’Acqua, Gourav Kumar, Kouadio Ibrahime Sinan, Stefania Sut, Irene Ferrarese, Mohamad Fawzi Mahomoodally, Roumita Seebaluck-Sandoram, Ouattara Katinan Etienne, Gokhan Zengin |
| ||Industrial Crops and Products. 2020; 147: 112226 |
|[Pubmed] | [DOI]|
||Potential Nutraceutical Properties of Leaves from Several Commonly Cultivated Plants
| ||Hafsa Amat-ur-Rasool, Fenella Symes, David Tooth, Larissa-Nele Schaffert, Ekramy Elmorsy, Mehboob Ahmed, Shahida Hasnain, Wayne G. Carter |
| ||Biomolecules. 2020; 10(11): 1556 |
|[Pubmed] | [DOI]|